You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Bionpharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Bionpharma
International Patents:10
US Patents:5
Tradenames:64
Ingredients:59
NDAs:69
Patent Litigation for Bionpharma: See patent lawsuits for Bionpharma

Drugs and US Patents for Bionpharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride CAPSULE;ORAL 022429-001 Jul 23, 2009 OTC Yes No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma MIDOL LIQUID GELS ibuprofen CAPSULE;ORAL 021472-001 Oct 18, 2002 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Bionpharma NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 217555-001 May 3, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma SEVELAMER CARBONATE sevelamer carbonate FOR SUSPENSION;ORAL 209374-001 May 17, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma ZONISAMIDE zonisamide CAPSULE;ORAL 077813-002 Aug 16, 2006 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma DROXIDOPA droxidopa CAPSULE;ORAL 213033-002 Apr 28, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Bionpharma Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0764174 SPC/GB04/031 United Kingdom ⤷  Try a Trial PRODUCT NAME: COLESEVELAM HYDROCHLORIDE; REGISTERED: UK EU/1/03/268/001-003 20040310
0716606 C300080 Netherlands ⤷  Try a Trial PRODUCT NAME: SEVELAMER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SEVELAMER HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/99/123/001-00420000128 20000128
0627406 SPC/GB11/026 United Kingdom ⤷  Try a Trial PRODUCT NAME: FINGOLIMOD, I.E. 2-AMINO-2-(2-(4-OCTYLPHENYL)ETHYL)PROPANE-1,3-DIOL, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/11/677/001 20110317; UK EU/1/11/677/002 20110317; UK EU/1/11/677/003 20110317; UK EU/1/11/677/004 20110317
0719278 SPC/GB03/018 United Kingdom ⤷  Try a Trial PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
1613288 CR 2011 00023 Denmark ⤷  Try a Trial PRODUCT NAME: FINGOLIMOD, HERUNDER FINGOLIMOD SOM HYDROCHLORID; REG. NO/DATE: EU/1/11/677/001-004 20110317
1110543 08C0004 France ⤷  Try a Trial PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.